-
Why Covid Patients Could Face A Lifetime Of Money Problems
Americans suffering from the condition are running into financial problems due to the inconsistent nature of the U.S. health-care system. -
Mother with ALS Seeks Life-Saving Drug from Biogen
CNBC's Meg Tirell joins ‘The News with Shepard Smith’ to report on one mother who is seeking help from an experimental drug to treat her terminal illness.Comments
-
Europe is Facing a 'Third-Wave' of Covid-19 Infections
In France, hospitals are under pressure while Italy is imposing new lockdowns.Comments
-
What Went Wrong With The U.S. Coronavirus Vaccine Rollout?
The U.S. coronavirus rollout has been anything but smooth. States are reporting limited supply of vaccines, leading them to delay appointments and close clinics to the public.Comments
-
Regeneron Antibody Drug Shown to Prevent Symptomatic Covid-19
Regeneron reported Tuesday that its antibody cocktail for coronavirus has show a reduction in overall infections seen within the first week, with 100% prevention of symptomatic infections.Comments
-
Lilly: Antibody Combo Cuts Covid Deaths, Hospitalizations by 70%
CNBC's Meg Tirrell reports on the latest news regarding drug treatments for Covid-19.Comments
-
Will Covid-19 Vaccine Passports Work?
A number of start-ups and major tech companies like Microsoft, Ticketmaster, Apple, and Google are interested in vaccine or immunization passports to help reopen the economy.Comments
-
How U.S. Airlines Transport Covid-19 Vaccines
Major U.S. airlines like American Airlines, United and Delta have stepped up to become a crucial part of the vaccine delivery supply chain alongside logistic giants like UPS, FedEx and DHL.Comments
-
The Most Hated Man In America?
Martin Shkreli, the notorious "Pharma bro," jacked up the price of a life-saving drug by 5,000% and is in prison for defrauding investors.Comments
-
Why Pfizer And Moderna Can't Be Sued For Covid Vaccine Side Effects
The U.S. began vaccinating the population against the coronavirus earlier this month, but mass adoption is not a guarantee.Comments
-
Covid-19 Vaccine Rollout Hits a Major Snag
Pfizer's vaccine rollout has hit a major snag as states say their supplies are getting cut.Comments
-
How The U.S. Plans To Distribute Covid-19 Vaccines
The initial doses of Pfizer and BioNTech's Covid-19 vaccines could go out next month, if the FDA grants emergency authorization.Comments
-
Remdesivir has Little Effect on Covid-19 Mortality: WHO Study
A new study by the World Health Organization said the antiviral drug remdesivir has "little to no effect on mortality" for those hospitalized with Covid-19.Comments
-
Johnson & Johnson Covid-19 Vaccine Study Paused Due to Unexplained Illness in Participant
The study of Johnson & Johnson's Covid-19 vaccine has been paused due to an unexplained illness in a study participant.Comments
-
Tracking President Donald Trump's Treatment for Covid-19
CNBC's Meg Tirrell takes a look at the treatments and experimental medicines President Trump is receiving for what experts are saying is a 'severe' case of Covid-19.Comments
Comments